Akoya Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €96.92M +8.9% -€28.86M -9.3% -29.8% +0.060 pp N/A N/A
    (estimated) €89.00M +8.7% -€31.83M -17.1% -35.8% +0.11 pp N/A N/A
    (estimated) €81.89M +9.5% -€38.38M -7.1% -46.9% +0.084 pp N/A N/A
    (estimated) €74.78M +10.7% -€41.31M -4.0% -55.2% +0.085 pp N/A N/A
    (estimated) €67.54M -4.0% -€43.03M -9.8% -63.7% +0.041 pp N/A N/A
    €70.36M -15.5% -€47.70M -12.6% -67.8% -0.023 pp -€35.88M -11.9% -51.0% -0.021 pp
    €83.25M +29.1% -€54.56M -10.4% -65.5% +0.29 pp -€40.70M +2.4% -48.9% +0.13 pp
    €64.49M +36.3% -€60.86M +64.5% -94.4% -0.16 pp -€39.75M +49.0% -61.6% -0.052 pp
    €47.31M +29.4% -€36.99M +157.0% -78.2% -0.39 pp -€26.69M +773.0% -56.4% -0.48 pp
    €36.57M +0.5% -€14.39M +13.3% -39.4% -0.044 pp -€3.06M -67.5% -8.4% +0.17 pp
    €36.39M -€12.71M -34.9% -€9.40M -25.8%

    Notifications